
1st Phorm’s ‘110% Money-Back Guarantee’
Money-back guarantee comes up woefully short of advertised percentage.
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Pending
Money-back guarantee comes up woefully short of advertised percentage.
Is it still a guarantee if it has strings attached?
Lawsuits allege “100%” marketing on front label is misleading.
TINA.org reader was charged a lot more than the advertised price. He’s not alone.
TINA.org explores the divide between the marketing and the science.